Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Chemed Corp Reaffirms FY 2013 EPS Guidance-Conference Call


Friday, 19 Apr 2013 10:00am EDT 

Chemed Corp announced that the management estimates fiscal 2013 earnings per diluted share (EPS), excluding non-cash expense for stock options, non-cash interest expense related to accounting for convertible debt, and other items not indicative of ongoing operations, will be in the range of $5.65 to $5.80 According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $5.70 for fiscal 2013. 

Company Quote

107.21
-1.17 -1.08%
21 Nov 2014